PA
GMED icon

Probity Advisors’s Globus Medical GMED Stock Holding History

Probity Advisors’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$275K Sell
3,475
-38
-1% -$3.23K 0.04% 207
2026
Q1 		$303K Sell
3,513
-15
-0.4% -$1.35K 0.05% 203
2025
Q4 		$308K Sell
3,528
-264
-7% -$20K 0.05% 197
2025
Q3 		$217K Buy
3,792
+199
+6% +$11.5K 0.04% 227
2025
Q2 		$212K Buy
+3,593
New +$232K 0.04% 226

Other funds holding GMED

BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
PM
Pembroke Management Montreal, Quebec, Canada $637M AUM 40.98% 1-Year Est. Return
AAS
Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Probity Advisors's GMED Position: Q2 2026 in Review

Probity Advisors reduced its Globus Medical (GMED) stake by 1.1% in Q2 2026, selling an estimated $3.23K and leaving 3,475 shares worth $275K. The position accounts for 0.04% of the portfolio, ranked #207.

Probity Advisors first reported a position in GMED in Q2 2025 and has held it in 5 quarters since. The position peaked at $308K in Q4 2025. 229 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Probity Advisors held 3,475 shares of Globus Medical worth $275K as of Q2 2026.
  • Probity Advisors sold 38 Globus Medical shares in Q2 2026, an estimated $3.23K.
  • Globus Medical made up 0.04% of Probity Advisors's portfolio in Q2 2026, its #207 holding.
  • Probity Advisors first reported a position in Globus Medical in Q2 2025 and has held it in 5 quarters since.
  • Probity Advisors's Globus Medical position peaked at $308K in Q4 2025.
  • 229 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Probity Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.